• October 2009
Cappello, Richetelli & Lee, JACR, 2018

State-level density reporting laws are associated with increased breast density awareness and increased likelihood of conversations between women and providers regarding supplemental screening.

JACR March, 2018

Women with Dense Breast Tissue have a higher-than-average risk of Breast Cancer.

Mandelson et al 2000

Breast Density is one of the strongest, if not the strongest, predictor of the failure of mammography screening to detect cancer.

Dr. Regina Hooley, ACR bulletin, 2012

We're finding small, mammographically occult cancers (Invisible on Mammogram) at a significant rate and we're able to do so and still be efficient.

American Medical Association Ethical Guidelines

Withholding medical information from patients without their knowledge or consent is ethically unacceptable.

Yaghjyan et al - JNCI 2011

Mammographic breast density is a well-established and strong predictor of breast cancer risk.

Karen Ravn Los Angeles Times

It may be the greatest risk factor you never heard of.

JAMA Oncology, 2017

Breast density exceeds other risk factors, including obesity, family history, and later in life childbirth.

Since October 2009

Connecticut becomes the first state to mandate Breast Density Notification - ushering in the Grassroots Breast Density Reporting Movement


Learn More


What's New?


In Remembrance

Celebrating the Life, Work & Legacy of Dr. Nancy Cappello

National Density Survey

JACR Study (Cappello, Richetelli & Lee) Women in States with Density Reporting Laws are more aware of breast density impact, prompting conversations betwen patient and provider

The Map Is All Pink!

On March 28, 2019, the Department of Health and Human Services, the FDA announced changes to the MQSA (Mammography Quality Standards Act) to include reporting of dense breast tissue to the patient...

Giving Women with Dense Breast
Tissue access to Early Detection.

State mandatory Breast Density notification

    Are You Dense Advocacy, Inc                  D.E.N.S.E.® State Map

Federal legislation to standardize density reporting becomes law in all 50 states and U.S. Territories. February 2019

In “read" from the FDA  “Breast Density”  


"The Committee recognizes the importance of patients receiving their own personal medical information and directs the FDA to ensure that Mammography reports and summaries received by patients and their providers include appropriate information about breast density specified by the Secretary, including, at a minimum, the effect of breast density in masking the presence of breast cancer on a mammogram, the qualitative assessment of the provider who interpreted the mammogram, and a reminder to patients that individuals with dense breast tissue should talk with their providers if they have any questions or concerns about their summary”.